{"id":35,"date":"2023-01-05T08:59:33","date_gmt":"2023-01-05T08:59:33","guid":{"rendered":"http:\/\/melinamasihi.axys.ai\/?page_id=35"},"modified":"2025-12-28T02:46:59","modified_gmt":"2025-12-28T02:46:59","slug":"home","status":"publish","type":"page","link":"https:\/\/www.melinamasihi.com\/","title":{"rendered":"HOME"},"content":{"rendered":"\n

<\/a><\/p>\n\n\n\n

\n
\n
\n
\n
\n
\n

Melina Masihi, M.D., PH.D.<\/h1>\n

Director of Practice Operations
\nDirector of Clinical Operations<\/h3>\n

A dynamic and strategic healthcare leader with a proven record of leading highly-successful multinational clinical trials, streamlining operations, procuring major funding, formulating top policy, and innovating processes to increase stakeholder value. A data-driven researcher with in-depth technical knowledge coupled with strong business acumen and operational expertise. An influential communicator and team leader who inspires collaboration, creativity, and top performance. Creates win-win solutions and readily embraces new challenges to drive organizational growth and deliver optimal patient care<\/p>\n

408-386-2515<\/span> melinamasihi@gmail.com<\/a><\/span><\/p>\n\n<\/div>\n<\/div>\n<\/div>\n

\n
<\/figure>
\n\t\t\t\t\t<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n<\/a>

<\/p>\n

\n
\n
\n

EXPERIENCE<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n\n
\n
\n

Stanford Health Innovation Fund
\nClinical & Translational Reviewer \/ Adviser April 2025<\/i><\/p>\n

<\/figure>

<\/p>\n

\nI serve as an external reviewer for the Stanford Health Innovation Fund (HIT Fund), where I evaluate early-stage digital health and biotechnology initiatives through the lens of clinical validity, translational science, and healthcare system impact. My work focuses on assessing scientific rigor, unmet clinical need, and the potential for scalable implementation to advance evidence-based, patient-centered care.<\/p>\n<\/div>\n<\/div>\n\n\n\n\n\n\n

\n
\n

Innotech Precision Medicine Inc.
\nField Medical Advisor Jan 2024<\/i><\/p>\n

<\/figure>

<\/p>\n

Advancing Diagnostic Innovation Through Medical Leadership.<\/b> <\/br>\nWith a strong foundation in medical affairs and cross-functional collaboration, I have contributed to the development and commercialization of cutting-edge diagnostic tools, including early detection platforms and biomarker-based assays. My work spans clinical trial design, regulatory strategy, and scientific communication. I\u2019ve partnered closely with R&D, regulatory, and commercial teams to ensure scientific accuracy and clinical relevance while engaging with KOLs to drive product value and real-world impact. From FDA submissions to conference presentations, I bring a strategic, evidence-based approach to advancing diagnostics that improve patient outcomes.<\/p>\n<\/div>\n<\/div>\n\n\n\n\n

\n
\n

AstraZeneca
\nMedical Science Liaison, Immunology (Contract) April 2023 | Sep 2023<\/i><\/p>\n

<\/figure>

<\/p>\n

Engage in scientific exchange with experts, identify study investigators, and provide actionable information to enhance the use of AZ products. Respond to inquiries with balanced clinical and scientific information, support appropriate product use, and deliver clinical differentiation of AstraZeneca products through regional and national data presentations.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Northwestern Hospital Feinberg School of Medicine,
\nDivision of Gastroenterology and Hepatology
\nDirector Clinical Program \/ Senior Medical Science Liaison
July 2014 | March 2023<\/i><\/p>\n

<\/figure>

<\/p>\n

I established professional relationships with KOLs in gastroenterology to support NIH studies, providing scientific and clinical information on Barrett’s Esophagus, IBD, and EOE. I conducted educational sessions, led NIH-funded research, and directed clinical trials. I generated insights from KOLs, collaborated with pharma companies, and actively participated in conferences. Ensuring compliance, I published research, spearheaded patient-centric initiatives, and coordinated with interdisciplinary teams to advance clinical research and support strategic alignment.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Anulex Technologies, Medical Device
\nMedical Science Liaison April 2011 | June 2014<\/i><\/p>\n

<\/figure>

<\/p>\n

I processed, reviewed, and organized patient data and records, managing clinical data forms from therapeutic groups and outside investigators. I oversaw operational aspects, including managing clinical research organizations requiring knowledge of drug and disease terminology. I gathered input from cross-functional teams, created plans for timely deliverables, and managed data, including preparation, validation, and writing specifications. I represented the Clinical Education Specialist team to align strategic plans and respond to scientific inquiries, integrating real-world evidence into clinical practice.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Silicon Valley Cloud IT LLC, Pleasanton, CA
\nDirector, Healthcare Advisor March 2008 | March 2011<\/i><\/p>\n

<\/figure>

<\/p>\n

I provided expert consulting services and technical advice to designers and engineering management, delivering required functionalities for healthcare administration products. I assessed client revenue cycle management capabilities and created strategies to improve performance and efficiency. I assembled platform requirements for F4CP, enabling new revenue sources and securing grants. I researched clinical solution integration, performed software workflow assessments, and conducted market research to guide product direction.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n<\/a>

<\/p>\n

\n
\n
\n

RESULTS<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\n
\n
\n
<\/figure>

<\/p>\n

Increased approach-acquisitions ratio from 10:2 to 10:8 by mitigating patient data security and cost concerns.<\/p>\n<\/div>\n<\/div>\n

\n
\n
<\/figure>

<\/p>\n

Secured a 5-year, $10M NIH grant by leveraging RO1 study success<\/p>\n<\/div>\n<\/div>\n

\n
\n
<\/figure>

<\/p>\n

Grew Biorepository Lab samples from 3,000 to 10,000 in one year and secured a $2M grant.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n<\/a>

<\/p>\n

\n
\n
\n

EXPERTISE<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n